1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Brain Concussion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abou-Donia, MB; Brahmajothi, MV | 1 |
| Aoyama, N; Katayama, Y; Kawamata, T; Maeda, T; Mori, T | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Brain Concussion
| Article | Year |
|---|---|
Monitoring from Battlefield to Bedside: Serum Repositories Help Identify Biomarkers, Perspectives on Mild Traumatic Brain Injury.
Topics: Adult; Biomarkers; Brain Concussion; Brain-Derived Neurotrophic Factor; Cohort Studies; Complement C3; Early Growth Response Protein 1; Female; Glial Fibrillary Acidic Protein; Humans; Interleukin-6; Longitudinal Studies; Male; Platelet Activating Factor; Retrospective Studies; S100 Calcium Binding Protein beta Subunit; Tumor Necrosis Factor-alpha; Warfare | 2020 |
Hemodynamic depression and microthrombosis in the peripheral areas of cortical contusion in the rat: role of platelet activating factor.
Topics: Animals; Brain Concussion; Cerebral Cortex; Cerebrovascular Circulation; Diazepam; Hemodynamics; Male; Platelet Activating Factor; Rats; Rats, Wistar; Thrombosis | 1997 |